VIVE · Vivesto AB · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in Vivesto AB securities by directors, senior managers and their closely associated persons, as published by the market regulator under the EU Market Abuse Regulation.
Director and related-person transactions
Source-reported director and related-person transactions, including amendments and historical rows. Not a complete insider-ownership register. Coverage is limited to captured publication days; gaps may exist between the first and last day. A verified issuer LEI includes other instruments of that issuer; an ISIN-only match covers that security. Instrument types and transaction descriptions are retained verbatim; do not sum revised, historical or derivative rows as share purchases. Publication timestamps are local source times.
| Transaction date | Person | Transaction | Instrument | Volume | Price | Status |
|---|---|---|---|---|---|---|
| 2026-07-03 | Peter Zonabend Chairman of the Board of Directors · Related person: Yes | Acquisition | Vivesto AB Share · SE0028925701 | 22000 Quantity | 8.7389 SEK | Current |
| 2026-01-22 | Peter Zonabend Chairman of the Board of Directors · Related person: Yes | Acquisition | Vivesto AB Share · SE0000722365 | 859940 Quantity | 0.1078 SEK | Current Ändring av ISIN-kod |
| 2026-01-22 | Peter Zonabend Chairman of the Board of Directors · Related person: Yes | Acquisition | Vivesto AB Share · SE0027301771 | 859940 Quantity | 0.1078 SEK | Revised |
| 2023-07-13 | Erik Kinnman Chief Executive Officer (CEO)/Managing Directory | Allotment | Personaloption 2023/2026 Option · | 3685578 Quantity | 0 SEK | Current |
| 2023-07-13 | Charles Sylvain Demmer Other member of the company's administrative, management or supervisory body | Allotment | Personaloption 2023/2026 Option · | 227042 Quantity | 0 SEK | Current |
| 2023-07-13 | Johanna Birgitta Dalborg Röstin Other senior executive | Allotment | Personaloption 2023/2026 Option · | 895.193 Quantity | 0 SEK | Current |
| 2023-07-13 | Kai Wilkinson Other senior executive | Allotment | Personaloption 2023/2026 Option · | 661664 Quantity | 0 SEK | Current |
| 2023-07-13 | Robert Maiorana Chief Financial Officer (CFO) | Allotment | Personaloption 2023/2026 Option · | 1264946 Quantity | 0 SEK | Current |
| 2022-03-22 | Francois-Regis Martelet Chief Executive Officer (CEO)/Managing Directory | Subscription | Oasmia Pharmaceutical AB BTA BTA · SE0017564958 | 12200 Quantity | 1.68 SEK | Current |
| 2022-03-22 | Peter Zonabend Member of the Board of Directors | Subscription | Oasmia BTA BTA · SE0017564958 | 120000 Quantity | 1.68 SEK | Current |
| 2021-12-19 | Francois-Regis Martelet Chief Executive Officer (CEO)/Managing Directory | Allotment | Personaloption 2021/2024 Option · | 2250000 Quantity | 0 SEK | Current |
| 2021-12-19 | Fredrik Järrsten Chief Financial Officer (CFO) | Allotment | Personaloption 2021/2024 Option · | 1350000 Quantity | 0 SEK | Current |
| 2021-08-19 | Anders Härfstrand Chairman of the Board of Directors | Acquisition | Aktie Share · SE0000722365 | 20000 Quantity | 2.656629 SEK | Current |
| 2021-07-16 | Peter Zonabend Member of the Board of Directors | Acquisition | Oasmia Pharmaceutical AB Share · SE0000722365 | 100000 Quantity | 3.026236 SEK | Current |
| 2021-07-14 | Fredrik Järrsten Chief Financial Officer (CFO) · Related person: Yes | Acquisition | Oasmia Pharmaceutical AB Share · SE0000722365 | 20000 Quantity | 2.91 SEK | Current |
| 2021-07-13 | Francois-Regis Martelet Chief Executive Officer (CEO)/Managing Directory | Acquisition | Oasmia Pharmaceutical AB Share · SE0000722365 | 41000 Quantity | 2.9602439 SEK | Current |
| 2021-07-08 | Birgit Agneta Stattin Norinder Member of the Board of Directors | Acquisition | Oasmia Pharmaceutical AB Share · SE0000722365 | 35000 Quantity | 2.98514286 SEK | Current |
| 2021-07-06 | Anders Härfstrand Chairman of the Board of Directors | Acquisition | Aktie Share · SE0000722365 | 100000 Quantity | 2.85653 SEK | Current |
| 2020-10-13 | Francois-Regis Martelet VD | Acquisition | Oasmia Pharmaceutical AB Share · SE0000722365 | 20000 Quantity | 4.25 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 100000 Quantity | 6.20638 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 80000 Quantity | 6.245176 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 77000 Quantity | 6.19035 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 77000 Quantity | 6.320203 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 77000 Quantity | 6.399018 SEK | Current |
| 2020-06-18 | Sven Rohmann Board member | Disposal | Oasmia Pharmaceutical AB – share Share · SE0000722365 | 78370 Quantity | 6.44 SEK | Current |
| 2019-12-04 | Neil Yman General manager | Acquisition | Oasmia Pharmaceutical AB BTA BTA · SE0010101188 | 75984 Quantity | 2 SEK | Current |
| 2019-12-04 | Sven Rohmann Board member and acting CEO | Subscription | Oasmia Pharmaceutical AB – BTA BTA · SE0013460557 | 720000 Quantity | 2 SEK | Current |
| 2019-12-04 | Jörgen Olsson Styrelseledamot/suppleant | Subscription | Oasmia Pharmaceutical AB BTA BTA · SE0010101188 | 720000 Quantity | 2 SEK | Current |
| 2019-12-04 | Anette Sjödin Vice VD | Subscription | Oasmia Pharmaceutical BTA 191118 BTA · SE0013460557 | 30000 Quantity | 2 SEK | Current |
| 2019-12-04 | Michael Carl Ewert af Winklerfelt Ekonomi/finanschef | Subscription | Oasmia Pharmaceutical AB BTA BTA · SE0010101188 | 37760 Quantity | 2 SEK | Current |
| 2019-12-04 | Gunilla Öhman Styrelseledamot/suppleant · Related person: Yes | Subscription | Oasmia Pharmaceutical BTA 191118 BTA · SE0013460557 | 40000 Quantity | 2 SEK | Current |
| 2019-11-29 | Nina Heldring ledningsgruppsmedlem | Acquisition | Oasmia Pharmaceutical TR Subscription right · SE0013460540 | 15105 Quantity | 1.7 SEK | Current |
| 2019-11-29 | Nina Heldring ledningsgruppsmedlem | Acquisition | OASMIA PHARMACEUTICAL BTA BTA · SE0002941799 | 12084 Quantity | 2 SEK | Current |
| 2019-11-29 | Michael Carl Ewert af Winklerfelt Ekonomi/finanschef | Acquisition | Oasmia Pharmaceutical AB TR Subscription right · SE0013460540 | 5367 Quantity | 1.74 SEK | Current |
| 2019-11-29 | Michael Carl Ewert af Winklerfelt Ekonomi/finanschef | Acquisition | Oasmia Pharmaceutical AB TR Subscription right · SE0013460540 | 24583 Quantity | 1.74 SEK | Current |
| 2019-11-27 | Peter Zonabend Styrelseledamot/suppleant | Subscription | Oasmia Pharmaceutical AB BTA BTA · SE0013460557 | 500000 Quantity | 2 SEK | Current |
| 2019-11-27 | Sven Rohmann Board member and acting CEO | Acquisition | Oasmia Pharmaceutical AB - TR Subscription right · SE0013460540 | 300000 Quantity | 1.453984 SEK | Current |
| 2019-11-27 | Sven Rohmann Board member and acting CEO | Acquisition | Oasmia Pharmaceutical AB - TR Subscription right · SE0013460540 | 110528 Quantity | 1.622 SEK | Current |
| 2019-11-27 | Sven Rohmann Board member and acting CEO | Acquisition | Oasmia Pharmaceutical AB - TR Subscription right · SE0013460540 | 400000 Quantity | 1.664332 SEK | Current |
| 2019-11-27 | Sven Rohmann Board member and acting CEO | Acquisition | Oasmia Pharmaceutical AB - TR Subscription right · SE0013460540 | 89472 Quantity | 1.834047 SEK | Current |
| 2019-11-26 | Jörgen Olsson Styrelseledamot/suppleant | Acquisition | Oasmia Pharmaceutical AB TR Subscription right · SE0013460540 | 900000 Quantity | 1.3152 SEK | Current |
| 2019-11-25 | Peter Zonabend Styrelseledamot/suppleant | Acquisition | Oasmia Pharmaceutical TR Subscription right · SE0013460540 | 625000 Quantity | 1.29 SEK | Current |
| 2019-11-25 | Anette Sjödin Vice VD | Acquisition | OASMIA Pharmaceutical TR Subscription right · SE0013460540 | 37500 Quantity | 1.3 SEK | Current |
| 2019-11-26 | Neil Yman General manager | Acquisition | oasmia Subscription right · SE0013460540 | 20000 Quantity | 1.37 SEK | Current |
| 2019-11-26 | MICHAEL CARL EWERT AF WINKLERFELT Ekonomi/finanschef | Acquisition | Oasmia Pharmaceutical AB TR Subscription right · SE0013460540 | 17250 Quantity | 1.31 SEK | Current |
| 2019-11-25 | Neil Eric Yman General manager | Acquisition | Oasmia pharmaceutical TR Subscription right · SE0013460540 | 67000 Quantity | 1.3 SEK | Current |
| 2019-11-25 | Neil Eric Yman General manager | Acquisition | oasmia pharmaceutical tr Subscription right · SE0013460540 | 7980 Quantity | 1.32 SEK | Current |
| 2019-11-25 | Gunilla Öhman Styrelseledamot/suppleant · Related person: Yes | Acquisition | Oasmia Pharmaceutical TR Subscription right · SE0013460540 | 50000 Quantity | 1.3 SEK | Current |
| 2019-07-05 | Peter Zonabend Styrelseledamot/suppleant · Related person: Yes | Exercise increase | Oasmia Pharmaceutical AB Share · SE0000722365 | 24193548 Quantity | 3.1 SEK | Current |
| 2019-07-05 | Peter Zonabend Styrelseledamot/suppleant · Related person: Yes | Exercise decrease | Oasmia Pharmaceutical AB Subcription warrant · SE0000722365 | 24193548 Quantity | 3.1 SEK | Current |
3783 publication days captured; dates between 2016-07-03 and 2026-11-12 may contain gaps. Checked 2026-11-13 11:51 UTC.